GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JS Link Inc (XKRX:127120) » Definitions » Cyclically Adjusted Revenue per Share

JS Link (XKRX:127120) Cyclically Adjusted Revenue per Share : ₩1,522.22 (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is JS Link Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

JS Link's adjusted revenue per share for the three months ended in Mar. 2025 was ₩62.787. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩1,522.22 for the trailing ten years ended in Mar. 2025.

During the past 12 months, JS Link's average Cyclically Adjusted Revenue Growth Rate was -5.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of JS Link was 0.30% per year. The lowest was -2.20% per year. And the median was -0.95% per year.

As of today (2025-06-01), JS Link's current stock price is ₩8640.00. JS Link's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ₩1,522.22. JS Link's Cyclically Adjusted PS Ratio of today is 5.68.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of JS Link was 14.51. The lowest was 1.53. And the median was 2.41.


JS Link Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for JS Link's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JS Link Cyclically Adjusted Revenue per Share Chart

JS Link Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,595.92 1,630.82 1,578.39 1,612.31 1,527.68

JS Link Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,617.87 1,574.10 1,556.44 1,527.68 1,522.22

Competitive Comparison of JS Link's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, JS Link's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JS Link's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, JS Link's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where JS Link's Cyclically Adjusted PS Ratio falls into.


;
;

JS Link Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, JS Link's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=62.787/122.5900*122.5900
=62.787

Current CPI (Mar. 2025) = 122.5900.

JS Link Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 493.436 100.051 604.597
201509 362.447 100.111 443.832
201512 330.443 100.220 404.199
201603 218.831 100.561 266.769
201606 421.394 100.791 512.534
201609 481.225 101.461 581.438
201612 647.233 101.561 781.245
201703 474.164 102.851 565.167
201706 560.251 102.611 669.333
201709 415.188 103.491 491.812
201712 547.365 102.991 651.529
201803 308.568 104.101 363.372
201806 369.434 104.130 434.925
201809 281.181 105.651 326.264
201812 344.745 104.351 405.002
201903 248.674 104.491 291.747
201906 266.957 104.881 312.033
201909 351.783 105.200 409.933
201912 418.266 105.121 487.772
202003 218.884 105.354 254.693
202006 302.854 105.112 353.213
202009 255.182 106.198 294.571
202012 408.175 105.765 473.105
202103 202.828 107.357 231.607
202106 298.528 107.579 340.184
202109 410.681 108.759 462.907
202112 488.066 109.676 545.532
202203 214.506 111.848 235.107
202206 227.457 114.072 244.441
202209 236.658 114.715 252.904
202212 330.791 115.179 352.075
202303 241.915 116.507 254.545
202306 284.468 117.182 297.596
202309 243.571 118.964 250.996
202312 489.178 118.837 504.626
202403 171.757 120.123 175.284
202406 162.782 120.007 166.285
202409 207.001 120.861 209.962
202412 253.271 121.135 256.313
202503 62.787 122.590 62.787

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


JS Link  (XKRX:127120) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

JS Link's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=8640.00/1522.22
=5.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of JS Link was 14.51. The lowest was 1.53. And the median was 2.41.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


JS Link Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of JS Link's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


JS Link Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JS Link Inc (XKRX:127120) » Definitions » Cyclically Adjusted Revenue per Share
Traded in Other Exchanges
N/A
Address
2F, Cluster Center, Bugahyeon-ro, Seodaemun-gu, Seoul, KOR
JS Link Inc Formerly DNA LINK Inc is a genomic service providing company based in Korea, focusing on research and development in the field of bio-industry and genomic analysis industry.

JS Link Headlines

No Headlines